Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 2
2003 6
2004 2
2005 4
2006 6
2007 5
2008 6
2009 8
2010 9
2011 7
2012 7
2013 3
2014 9
2015 8
2016 6
2017 15
2018 16
2019 8
2020 14
2021 11
2022 15
2023 9
2024 15
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
REPLY.
Poli E, Verstuyft C, Guettier C, Duclos Vallée JC. Poli E, et al. Among authors: verstuyft c. Hepatology. 2021 Jun;73(6):2616. doi: 10.1002/hep.31635. Hepatology. 2021. PMID: 33200416 No abstract available.
Editorial.
Becquemont L, Picard N, Verstuyft C. Becquemont L, et al. Among authors: verstuyft c. Therapie. 2017 Apr;72(2):173-174. doi: 10.1016/j.therap.2017.01.004. Epub 2017 Jan 30. Therapie. 2017. PMID: 28238399 No abstract available.
Comment faciliter la diffusion des tests de pharmacogénétique ?
Verstuyft C, Dewolf D, Blin O, Florentin V, Mesnard L, Chaumette B, Ayme-Dietrich E, Raymond L, Lang M, Lamazière A, Allard B, Samelson L, Lamezec L, Loriot MA, Le Bozec A, Picard N. Verstuyft C, et al. Therapie. 2025 Jan-Feb;80(1):93-102. doi: 10.1016/j.therap.2024.11.007. Epub 2024 Dec 5. Therapie. 2025. PMID: 39710540 French. No abstract available.
Éditorial.
Becquemont L, Picard N, Verstuyft C. Becquemont L, et al. Among authors: verstuyft c. Therapie. 2017 Apr;72(2):171-172. doi: 10.1016/j.therap.2016.12.008. Epub 2017 Jan 3. Therapie. 2017. PMID: 28117096 French. No abstract available.
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Milisavljevic B, Gervais A, Bastard P, Asano T, Bizien L, Barzaghi F, Abolhassani H, Abou Tayoun A, Aiuti A, Alavi Darazam I, Allende LM, Alonso-Arias R, Arias AA, Aytekin G, Bergman P, Bondesan S, Bryceson YT, Bustos IG, Cabrera-Marante O, Carcel S, Carrera P, Casari G, Chaïbi K, Colobran R, Condino-Neto A, Covill LE, Delmonte OM, El Zein L, Flores C, Gregersen PK, Gut M, Haerynck F, Halwani R, Hancerli S, Hammarström L, Hatipoğlu N, Karbuz A, Keles S, Kyheng C, Leon-Lopez R, Franco JL, Mansouri D, Martinez-Picado J, Metin Akcan O, Migeotte I, Morange PE, Morelle G, Martin-Nalda A, Novelli G, Novelli A, Ozcelik T, Palabiyik F, Pan-Hammarström Q, de Diego RP, Planas-Serra L, Pleguezuelo DE, Prando C, Pujol A, Reyes LF, Rivière JG, Rodriguez-Gallego C, Rojas J, Rovere-Querini P, Schlüter A, Shahrooei M, Sobh A, Soler-Palacin P, Tandjaoui-Lambiotte Y, Tipu I, Tresoldi C, Troya J, van de Beek D, Zatz M, Zawadzki P, Al-Muhsen SZ, Alosaimi MF, Alsohime FM, Baris-Feldman H, Butte MJ, Constantinescu SN, Cooper MA, Dalgard CL, Fellay J, Heath JR, Lau YL, Lifton RP, Maniatis T, Mogensen TH, v… See abstract for full author list ➔ Matuozzo D, et al. Genome Med. 2023 Apr 5;15(1):22. doi: 10.1186/s13073-023-01173-8. Genome Med. 2023. PMID: 37020259 Free PMC article.
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
176 results